Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
Abstract 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem c...
Main Authors: | Reinhard Stöger, Paula J. Scaife, Freya Shephard, Lisa Chakrabarti |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-02-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-017-0007-3 |
Similar Items
-
5-Hydroxymethylcytosine (5-hmC) Specific Enrichment
by: Keith Szulwach, et al.
Published: (2012-08-01) -
Global DNA 5hmC and CK19<sup>5hmC+</sup> Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
by: Jinhua Jiang, et al.
Published: (2021-09-01) -
Regulation of molecular subtypes of pancreatic cancer by TET2 and 5'hmC
by: Eyres, MMD
Published: (2019) -
The crucial role of 5hmC in neuroprotection and repair after cerebrovascular injury
by: Yanina Tsenkina
Published: (2024-07-01) -
Supplemental Herbal Choline Increases 5-hmC DNA on Whole Blood from Pregnant Ewes and Offspring
by: José Alejandro Roque-Jiménez, et al.
Published: (2020-07-01)